Gate2Brain
Latest round
- Series D
Last raised
- Dec 2022
Total raised
- $2.7M
Investors
- 1
About Gate2Brain
Gate2Brain specializes in developing therapeutics aimed at overcoming biological barriers, particularly for treating rare pediatric solid tumors. Founded by Esther Riambau, Gloria de Rozas, and Marc Castelltort, the company is headquartered in Barcelona, Spain.Gate2Brain (G2B) focuses on developing therapeutics that can effectively penetrate biological barriers, with G2B-002 being their primary product. This innovative treatment utilizes a peptide-based technology platform to enhance the efficacy of various therapeutic agents, targeting rare pediatric solid tumors. The company has received Orphan Drug Designation from the European Medicines Agency and the US FDA for G2B-002, indicating its commitment to addressing significant unmet medical needs within oncology and rare diseases.Gate2Brain's revenue structure is primarily based on partnerships and collaborations with pharmaceutical companies and research institutions. The company engages in licensing agreements and co-development partnerships to share risks and resources involved in the lengthy drug development process. While details on pricing for G2B-002 are not disclosed, pricing strategies are expected to consider developmental milestones, regulatory approvals, and market demand in the pediatric oncology sector. The company aims to expand its reach within the pediatric oncology market in Europe and the United States, with a focus on bringing G2B-002 to market. Additionally, Gate2Brain is strategizing future product launches, although specific timelines have yet to be finalized.
Who invested in Gate2Brain
1 investor across 1 round
See all investors in Gate2Brain
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 21, 2022
Amount
$2.7M
Investors
Questions about Gate2Brain
Who invested in Gate2Brain?
Gate2Brain has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gate2Brain raised?
Gate2Brain has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gate2Brain last raise money?
Gate2Brain's most recent round on record is a Series D, in Dec 2022.
What does Gate2Brain do?
Gate2Brain specializes in developing therapeutics aimed at overcoming biological barriers, particularly for treating rare pediatric solid tumors.
Where is Gate2Brain headquartered?
Gate2Brain is headquartered in Barcelona, Spain.
Which VCs invest in companies like Gate2Brain?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Gate2Brain's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Gate2Brain? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.